A delayed class of BOLD waveforms associated with spreading depression in the feline cerebral cortex can be detected and characterised using independent component analysis (ICA).
An application of independent component analysis to blood oxygenation level- dependent MRI (BOLD-MRI) results was used to detect cerebrovascular changes that followed the initiation of cortical spreading depression (CSD) in feline brain. The cortical images were obtained from a horizontal plane at 28 s intervals before, and for 1.4-1.75 h after, KCl dissolved in agar (KCl/agar) had been directly applied to the left suprasylvian gyrus of 13 anesthetized cats for 10 min. It successfully resolved, for the first time, a novel class of prolonged, and delayed, biphasic BOLD waveforms. These were larger in amplitude ( approximately 20%), longer lasting and more delayed in onset (13-33 min) than the brief propagating (90 s) BOLD increase ( approximately 4%) already known to be associated with CSD on earlier occasions. Furthermore, such changes occurred in localized regions on the hemisphere ipsilateral to the site of stimulus application in 4 out of 5 control subjects rather than themselves generating propagating waves. Finally, the biphasic waveforms were consistently abolished in the 4 experimental animals studied following the i.v. administration of sumatriptan (0.3 mg kg(-1)), an antimigraine 5-HT(1B/1D) agonist, 15 min before the application of the transient stimulus. They were abolished in 2 out of 4 animals following the intraperitoneal (i.p.) administration of SB-220453 (tonabersat: 10 mg kg(-1), 90 min before stimulus application), a novel anticonvulsant that has recently been reported to inhibit CSD. ICA has thus been successful in detecting a novel localized, as opposed to propagating, signal of potential physiological significance hidden in complex BOLD- MRI data, whose sensitivity to sumatriptan may relate it to the cerebrovascular changes reported in the headache phase of migraine.
Netsiri
Chaiyapoj
C
Physiological Laboratory, University of Cambridge, Downing Street, CB2 3EG Cambridge, UK.
Bradley
Daniel P
DP
Takeda
Tsunehiro
T
Smith
Martin I
MI
Papadakis
Nikolas
N
Hall
Laurance D
LD
Parsons
Andrew A
AA
James
Michael F
MF
Huang
Christopher L-H
CL
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D016477:Artifacts; D001549:Benzamides / Q000494:pharmacology; D001578:Benzopyrans / Q000494:pharmacology; D002415:Cats; D002540:Cerebral Cortex / Q000187:drug effects / Q000502:physiology*; D002560:Cerebrovascular Circulation / Q000187:drug effects / Q000502:physiology; D013181:Cortical Spreading Depression / Q000187:drug effects / Q000502:physiology*; D005260:Female; D008279:Magnetic Resonance Imaging / Q000379:methods*; D058825:Serotonin 5-HT1 Receptor Agonists; D018170:Sumatriptan / Q000494:pharmacology
D000927:Anticonvulsants; D001549:Benzamides; D001578:Benzopyrans; D058825:Serotonin 5-HT1 Receptor Agonists; C118706:tonabersat; D018170:Sumatriptan